New method of finding drugs more important than new antibiotic itself

January 12, 2015 by Diana Lutz

It was big news this week when Nature published the discovery of a new antibiotic, teixobactin. Teixobactin, which kills bacteria by a different pathway than other antibiotics, represented the first new class of antibiotics to be discovered in 30 years. Not only did the Northeastern University scientists who discovered the drug say it was "exceptionally well-protected from resistance development," it also, remarkably, was grown in the dirt, not on a culture plate.

"A key innovation was the use of outdoor soil itself as an incubator to culture organisms that cannot be propagated by artificial laboratory conditions," said Michael S. Kinch, PhD, associate vice chancellor and director of the Center for Research Innovation in Business at Washington University in St. Louis, who has written extensively about the pharmaceutical industry and the dearth of new antibiotics.

One of the little known secrets of the laboratory is that only one in 100 bacterial strains will actually grow in the lab. Kinch says the new method for finding is even more exciting than the discovery of teixobactin, and likely to have a bigger payoff in the end.

"The novel process reported in the Nature paper is particularly elegant by blending common sense and innovation," Kinch said. "The great majority of bacteria on the planet have yet to be described, in part because they cannot be cultured in the laboratory. Scientists at Northeastern University developed a way to isolate and grow individual quite literally in their own back yard (as the devices were buried in the yards of some of the investigators). This same methodology could revolutionize the discovery of new medicines well beyond anti-bacterial agents."

Kinch believes the concept of modeling a "real-world" environment could foster fundamental discoveries that impact other fields.

"For example, a human cancer does not cause disease when grown in current laboratory conditions (such as two-dimensional plastic or three-dimensional gelatinous mixtures), but rather in a living, breathing person," he said.

"Thus, the findings published this week could serve as a springboard for all scientists and physicians to thoughtfully re-consider how they design and interpret their work. The ultimate benefits for improving patient care could be extraordinary."

Explore further: New approach sees breakthrough in antibiotics research

Related Stories

New approach sees breakthrough in antibiotics research

January 7, 2015
Scientists using a revolutionary approach have devised an antibiotic that may offset the mounting problem of drug resistance for decades, they said on Wednesday.

The dwindling stock of antibiotics, and what to do about it

October 10, 2014
The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. (Twenty-three thousand die.) These experiences leave deep impressions ...

Mining data for the history of pharmaceutical development

April 30, 2014
(Medical Xpress)—Yale's Michael Kinch spent his spare time in the last year creating a massive database that encompasses the entire history of drug development in the United States. In a series of 20 articles scheduled ...

Antibiotic resistance is a gut reaction

December 16, 2014
Scientists from the Institute of Food Research and the University of East Anglia have discovered how certain gut bacteria can protect themselves and others in the gut from antibiotics.

Old drug may be key to new antibiotics

September 22, 2014
McMaster scientists have found that an anticonvulsant drug may help in developing a new class of antibiotics.

Predicting antibiotic resistance

December 17, 2014
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By ...

Recommended for you

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.